Central Pacific Bank - Trust Division’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,180
Closed -$225K – 923
2026
Q2
$225K Buy
3,180
+750
+31% +$40.5K 0.02% 451
2026
Q1
$127K Buy
2,430
+140
+6% +$8.4K 0.02% 555
2025
Q4
$135K Sell
2,290
-960
-30% -$58.3K 0.02% 508
2025
Q3
$181K Sell
3,250
-390
-11% -$20.9K 0.02% 472
2025
Q2
$187K Buy
3,640
+570
+19% +$28.6K 0.02% 450
2025
Q1
$180K Buy
3,070
+760
+33% +$51.5K 0.02% 462
2024
Q4
$166K Buy
2,310
+210
+10% +$15.4K 0.02% 498
2024
Q3
$168K Sell
2,100
-4,829
-70% -$363K 0.02% 484
2024
Q2
$496K Buy
6,929
+750
+12% +$55.2K 0.06% 313
2024
Q1
$429K Buy
+6,179
New +$442K 0.05% 375

Other funds holding TECH

Central Pacific Bank - Trust Division's TECH Position: Q3 2026 in Review

Central Pacific Bank - Trust Division sold out of Bio-Techne (TECH) in Q3 2026, closing a stake of 3,180 shares — an estimated $225K sold.

Central Pacific Bank - Trust Division first reported a position in TECH in Q1 2024 and held it in 10 quarters. The position peaked at $496K in Q2 2024. 15 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Central Pacific Bank - Trust Division reported no remaining Bio-Techne position as of Q3 2026 after selling out during the quarter.
  • Central Pacific Bank - Trust Division sold 3,180 Bio-Techne shares in Q3 2026, an estimated $225K.
  • Central Pacific Bank - Trust Division first reported a position in Bio-Techne in Q1 2024 and held it in 10 quarters.
  • Central Pacific Bank - Trust Division's Bio-Techne position peaked at $496K in Q2 2024.
  • 15 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.